House Representatives Worried OTC Plan B May Increase Adolescent STD Risk

Political pressure could affect the pending FDA decision on Barr Labs' application for over-the-counter status for emergency contraceptive Plan B (levonorgestrel)

More from Archive

More from Pink Sheet